US Government Policy Shift Prompts Pharmaceutical Warnings Over Reduced Vaccine Demand
The Trump administration has reduced the childhood vaccine schedule from 17 to 11 diseases. Major executives warn this shift is lowering vaccination rates.
Insights:
The administration of President Donald Trump donald trumphas implemented a significant change to the US 
USchildhood vaccine schedule, reducing the number of recommended diseases from 17 to 11. This policy shift, enacted in early January 2026, bypassed the standard outside expert review process typically conducted by the U.S. Centers for Disease Control and Prevention. The move follows the appointment of Robert F. Kennedy Jr. robert f kennedy jras Health Secretary, who previously oversaw the removal of universal recommendations for COVID-19 and hepatitis B shots for children.
USchildhood vaccine schedule, reducing the number of recommended diseases from 17 to 11. This policy shift, enacted in early January 2026, bypassed the standard outside expert review process typically conducted by the U.S. Centers for Disease Control and Prevention. The move follows the appointment of Robert F. Kennedy Jr. robert f kennedy jras Health Secretary, who previously oversaw the removal of universal recommendations for COVID-19 and hepatitis B shots for children.Industry leaders speaking at the J.P. Morgan Healthcare Conference in San Francisco expressed deep concerns regarding the commercial and public health implications of these changes. Paul Hudson paul hudson, the CEO of Sanofi SA , stated that the company anticipates weakness in vaccine demand within the USthroughout 2026. This forecast follows a reported decline in vaccine sales for Sanofi SAduring the third quarter of 2025, which Paul Hudsonattributed to the effects of misinformation and policy uncertainty.
